Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
4.950
+0.200 (4.21%)
Jan 22, 2026, 4:00 PM EST - Market closed
Artiva Biotherapeutics Market Cap
Artiva Biotherapeutics has a market cap or net worth of $121.5 million as of January 23, 2026. Its market cap has decreased by -52.81% in one year.
Market Cap
121.50M
Enterprise Value
10.22M
1-Year Change
-52.81%
Ranking
Category
Stock Price
$4.95
Market Cap Chart
Since the IPO on July 19, 2024, Artiva Biotherapeutics's market cap has decreased from $176.76M to $121.50M, a decrease of -31.26%. That is a compound annual growth rate of -21.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 121.50M | 15.38% |
| Dec 31, 2025 | 105.30M | -56.99% |
| Dec 31, 2024 | 244.84M | 38.52% |
| Jul 19, 2024 | 176.76M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 116.09M |
| Acumen Pharmaceuticals | 114.00M |
| Agenus | 113.93M |
| MacroGenics | 113.87M |
| Repare Therapeutics | 111.44M |
| Karyopharm Therapeutics | 110.59M |
| Tharimmune | 109.17M |
| Fortress Biotech | 107.70M |